Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2025)

Historic Total Liabilities for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $27.7 million.

  • Camp4 Therapeutics' Total Liabilities rose 5241.86% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 5241.86%. This contributed to the annual value of $15.2 million for FY2024, which is 826.43% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Total Liabilities of $27.7 million as of Q3 2025, which was up 5241.86% from $11.3 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Total Liabilities peaked at $111.6 million during Q3 2023, and registered a low of $11.2 million during Q1 2025.
  • In the last 3 years, Camp4 Therapeutics' Total Liabilities had a median value of $16.5 million in 2023 and averaged $30.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 8369.16% in 2024, then soared by 5241.86% in 2025.
  • Camp4 Therapeutics' Total Liabilities (Quarter) stood at $16.5 million in 2023, then fell by 8.26% to $15.2 million in 2024, then surged by 82.87% to $27.7 million in 2025.
  • Its Total Liabilities stands at $27.7 million for Q3 2025, versus $11.3 million for Q2 2025 and $11.2 million for Q1 2025.